Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Month: September 2018

Why aging isn’t a way out if you’re tired of living…

Suppose that, at a point, you get completely, irreparably tired of life and want to die. In these circumstances, how willing would you be to bear with around twenty more years of the same life that you can’t stand any more, particularly in a state of declining health? It would seem more reasonable that if you are tired of life right now and you are absolutely certain that you will not change your mind, you would rather end your life at once than wait for two more, increasingly miserable, decades. Yet, there is a certain narrative suggesting that the decay of old age, which inevitably leads to death, is an acceptable option for people who are sure that they are through with life.

Warning: spoilers

In a moment, I will be revealing the ending of a recent podcast titled “The 200-year-old”—an interesting and, all-in-all, rejuvenation-friendly series. It is only four episodes long, and if you haven’t listened to it yet, I would say that it is worth your time. If you wish to do so, stop reading right now to avoid spoilers. (Do come back to finish the article once you’re done with the podcast, though.)

Read more

As of June, a total of 31 states and the District of Columbia allow for the use of medical marijuana. Pain is the most common reason people say they need this cannabis and the vast majority of users say that it helps. However, despite the claims of the many individuals who believe that cannabinoids — the chemicals in marijuana — can ease pain, it’s been difficult for scientists to explain why. Researchers published in JAMA Psychiatry now claim to clarify the discrepancy.

In a systematic review and meta-analysis released Wednesday, scientists from Syracuse University explain that while studies can’t currently prove that cannabinoid drugs reduce pain, research does demonstrate that they can help with the experience of feeling pain. An evaluation of 18 studies that included 442 adults revealed that the use of cannabinoid drugs modestly increased people’s threshold for pain and reduced pain’s overall sensation of unpleasantness. This suggests to the researchers that cannabis’ analgesic properties, or ability to relieve pain, affect the mind rather than the body.

“This [result] is especially salient because managing chronic pain is not solely about minimizing pain,” Kevin Boehnke, Ph.D., who was not involved in the study, tells Inverse. Boehnke is currently a part of a University of Michigan study also analyzing the effect of cannabis on chronic pain. “Sleep problems, fatigue, anxiety, depression, and other factors tie into the experience of chronic pain.”

Read more

Since cognitive computing can process massive amounts of data that no human could ever digest and imitate the human brain like no computer system ever has, the technology has amazing potential to amplify our abilities — not replace us — and help us make better, data-driven decisions.

As marketers, we always want to get better. Refining our process and strategy to solve our customers’ problems is our mission. But to understand which tactics actually work and which ones don’t, we usually need to analyze huge sets of complex data.

Data analysis can seem like a tall task, especially if you’re more of a creative marketer. But today, cognitive computing can crunch the numbers for you, helping you make better decisions faster, and hone important aspects of your brand, like brand voice, reporting, and customer support.

Read more

Today, we would like to share a talk given by Stephen Hilbert, President of Oisin Biotechnologies, in which he discusses treating aging and cancer by removing harmful senescent cells.

On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. The packed event saw a range of people from research, investment, and the wider community coming together for a day of science and biotech business presentations and panels.

One of the companies at the event was Oisin Biotechnologies, a company working on therapies that remove harmful senescent cells, which accumulate as we age and drive aging processes through the senescence-associated secretory phenotype (SASP), which leads to chronic inflammation.

Read more

Do you think NASA needs a new logo?

Michael D. Shaw is a biochemist and freelance writer. A graduate of the University of California, Los Angeles, and a protégé of the late Willard Libby, winner of the 1960 Nobel Prize in chemistry, Shaw also did postgraduate work at MIT. Based in Virginia, he covers technology, health care and entrepreneurship, among other issues.

NASA’s logo needs a refresh. The agency’s official logo, the 59-year-old “meatball insignia,” features a sphere to represent a planet, stars to represent space and a red chevron or “wing” to represent aeronautics, with white N-A-S-A lettering in the center. This logo looks like it belongs in a museum, commemorating the past, not celebrating the future. As NASA celebrates its 60th anniversary this year, this seems like a good time for the agency to update its antiquated logo.

Read more

Blue Origin is making the final preparations for crewed spaceflight in West Texas. Meanwhile, at Cape Canaveral, Florida, the company is continuing to push towards achieving orbit and entering the commercial launch market. During a speech this week, Jeff Bezos confirmed the company has already invested $1 Billion in space coast facilities and another $1 billion will be fed into the New Glenn rocket next year.

The New Shepard rocket, named after the first American in space Alan Shepard, is designed for suborbital space tourism. Passengers can experience a few minutes of weightless as the spacecraft flies up to 107 km, 7 km above the officially recognized Karman Line between Earth’s atmosphere and space. New Shepard first reached this altitude on Flight 8 in April.

The New Shepard 3 vehicle completed the most recent test flight in July, demonstrating the crew capsule’s escape system at the edge of the flight envelope. Flight 9 was the latest in a line of flights designed to demonstrate the safety of the crew vehicle, including another in-flight abort test in 2016, a pad abort test back in 2012, and a parachute redundancy test in 2016 where the capsule descended under only 2 of the 3 parachutes.

Read more

http://www.blogtalkradio.com/unlimited-realities-with-lisa-zimmer/2018/09/20/hope-for-our-health-future